| 1 |
34591983 | Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype. | 2022 Feb 15 |
1 |
| 2 |
33846524 | Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort. | 2021 Jul |
2 |
| 3 |
33238621 | Clinicopathological and Molecular Profiles of Sporadic Microsatellite Unstable Colorectal Cancer with or without the CpG Island Methylator Phenotype (CIMP). | 2020 Nov 23 |
1 |
| 4 |
30407260 | The dark side of the colon: current issues surrounding the significance, prevalence, detection, diagnosis and management of serrated polyps. | 2019 Jan |
1 |
| 5 |
30753821 | The Origin of CIMP, At Last. | 2019 Feb 11 |
1 |
| 6 |
31933925 | Relationship between CpG island methylation phenotype, microsatellite instability phenotype and mutation of KRAS, NRAS, and BRAF genes in colorectal cancer. | 2019 |
1 |
| 7 |
28542846 | CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers. | 2017 Sep 1 |
2 |
| 8 |
26512054 | Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors. | 2016 Jan |
2 |
| 9 |
26702772 | Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. | 2016 Jun |
1 |
| 10 |
26963001 | Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis. | 2016 Mar 10 |
2 |
| 11 |
27272216 | Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. | 2016 Jun 14 |
1 |
| 12 |
27404270 | Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis. | 2016 |
1 |
| 13 |
27811854 | No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. | 2016 Nov 22 |
1 |
| 14 |
24752710 | MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions. | 2014 Dec 1 |
1 |
| 15 |
24812557 | The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort. | 2014 |
2 |
| 16 |
25005754 | A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma. | 2014 Jul 8 |
1 |
| 17 |
25367952 | MAFG mediates CIMP in BRAF-mutant colorectal cancer. | 2014 Nov |
2 |
| 18 |
25496513 | Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype. | 2014 Nov |
2 |
| 19 |
26134964 | Molecular features of colorectal polyps presenting Kudo's type II mucosal crypt pattern: are they based on the same mechanism of tumorigenesis? | 2014 Sep |
1 |
| 20 |
23341177 | Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype. | 2013 May |
1 |
| 21 |
21557216 | p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. | 2012 Apr 1 |
1 |
| 22 |
23323463 | [Genetic and epigenetic changes in colorectal cancer and genetic testing for personalized medicine]. | 2012 Oct |
1 |
| 23 |
21036793 | Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. | 2011 Mar |
1 |
| 24 |
21423154 | Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. | 2011 Jul |
1 |
| 25 |
21507361 | DNA methylation changes in cancer. | 2011 |
1 |
| 26 |
21660972 | Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features. | 2011 Nov |
1 |
| 27 |
21827707 | The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy. | 2011 Aug 10 |
1 |
| 28 |
21915661 | [Chromosomal instability, microsatellite instability and CpG island methylator phenotype: roles in small intestinal carcinogenesis]. | 2011 Nov |
1 |
| 29 |
22977561 | Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner. | 2011 Jul |
1 |
| 30 |
19638426 | IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. | 2010 Mar |
1 |
| 31 |
20028768 | Three DNA methylation epigenotypes in human colorectal cancer. | 2010 Jan 1 |
1 |
| 32 |
20444249 | Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition? | 2010 May 5 |
1 |
| 33 |
20492682 | Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. | 2010 May 21 |
1 |
| 34 |
18832519 | CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. | 2009 Jan |
1 |
| 35 |
19787768 | Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. | 2009 Oct |
1 |
| 36 |
19911194 | Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. | 2009 Dec |
1 |
| 37 |
18068703 | Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma. | 2008 Feb |
1 |
| 38 |
18199160 | Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation. | 2008 Feb |
2 |
| 39 |
18435933 | Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. | 2008 Jun |
5 |
| 40 |
18451217 | Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. | 2008 May 1 |
3 |
| 41 |
18517279 | Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instability. | 2008 Jun |
1 |
| 42 |
18782444 | BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? | 2008 Sep 9 |
1 |
| 43 |
18829479 | CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. | 2008 Oct 1 |
1 |
| 44 |
18834226 | CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. | 2008 Oct |
2 |
| 45 |
19002263 | Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. | 2008 |
1 |
| 46 |
19117505 | Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. | 2008 Dec 31 |
1 |
| 47 |
17086168 | Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. | 2007 Jan |
1 |
| 48 |
17239930 | Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype. | 2007 Apr |
1 |
| 49 |
17270239 | TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer. | 2007 Apr |
1 |
| 50 |
17591929 | Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. | 2007 Jul |
1 |